Effects of Cholinesterase Inhibitors on Visual Attention in Mild Alzheimer's Disease

被引:0
|
作者
Daiello, Lori A. [1 ]
Ott, Brian R. [1 ]
Festa, Elena K. [2 ]
Heindel, William C. [2 ]
机构
[1] Rhode Isl Hosp, Alzheimers Dis & Memory Disorders Ctr, Providence, RI USA
[2] Brown Univ, Dept Psychol, Providence, RI 02912 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:S89 / S89
页数:1
相关论文
共 50 条
  • [41] Switching cholinesterase inhibitors in patients with Alzheimer's disease
    Emre, M
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, : 64 - 72
  • [42] Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer's disease
    Jönsson, L
    PHARMACOECONOMICS, 2003, 21 (14) : 1025 - 1037
  • [43] Pharmacoeconomics of cholinesterase inhibitors in the treatment of Alzheimer’s disease
    Linus Jönsson
    PharmacoEconomics, 2003, 21 : 1025 - 1037
  • [44] ADHERENCE TO CHOLINESTERASE INHIBITORS IN PATIENTS WITH ALZHEIMER'S DISEASE
    Blais, Lucie
    Kettani, Fatima-Zohra
    Perreault, Sylvie
    Leroux, Jean-Christophe
    Forget, Amelie
    Kergoat, Marie-Jeanne
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2009, 57 (02) : 366 - 368
  • [45] Treatment of advanced Alzheimer's disease with cholinesterase inhibitors
    Korczyn, Amos D.
    ALZHEIMERS & DEMENTIA, 2008, 4 (05) : 371 - 372
  • [47] Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly
    Vandenberg, CM
    Kazmi, Y
    Jann, MW
    DRUGS & AGING, 2000, 16 (02) : 123 - 138
  • [48] Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
    Tayeb, Haythum O.
    Yang, Hyun Duk
    Price, Bruce H.
    Tarazi, Frank I.
    PHARMACOLOGY & THERAPEUTICS, 2012, 134 (01) : 8 - 25
  • [49] Comparison studies of cholinesterase inhibitors for Alzheimer's disease
    Hogan, DB
    Goldlist, B
    Naglie, G
    Patterson, C
    LANCET NEUROLOGY, 2004, 3 (10): : 622 - 626
  • [50] Cholinesterase Inhibitors for the Treatment of Alzheimer’s Disease in the Elderly
    Chad M. VanDen Berg
    Yusuf Kazmi
    Michael W. Jann
    Drugs & Aging, 2000, 16 : 123 - 138